D. E. Shaw & Co., Inc. Bristol Myers Squibb CO Put Options Transaction History

D. E. Shaw & Co., Inc.

$98.6 Billion
Q2 2024

Put Options

28 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $47.5 Million - $62.6 Million	1,180,600 Added 59.43%	3,167,200 $132 Million
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $30 Million - $34 Million	624,500 Added 45.85%	1,986,600 $108 Million
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $13.1 Million - $15.6 Million	-269,400 Reduced 16.51%	1,362,100 $69.9 Million
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $33.9 Million - $37.9 Million	584,800 Added 55.87%	1,631,500 $94.7 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $3.82 Million - $4.24 Million	60,000 Added 6.08%	1,046,700 $66.9 Million
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $80.7 Million - $91.5 Million	-1,227,400 Reduced 55.44%	986,700 $68.4 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $56.8 Million - $67.2 Million	829,100 Added 59.86%	2,214,100 $159 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $62,595 - $37 Million	-481,500 Reduced 25.8%	1,385,000 $98.5 Million
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $54.5 Million - $60.1 Million	751,100 Added 67.34%	1,866,500 $144 Million
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $14.3 Million - $17.2 Million	-232,700 Reduced 17.26%	1,115,400 $81.5 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $29.7 Million - $34.6 Million	554,200 Added 69.81%	1,348,100 $84.1 Million
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $15.4 Million - $18.1 Million	260,800 Added 48.92%	793,900 $47 Million
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $9.19 Million - $10 Million	-148,400 Reduced 21.78%	533,100 $35.6 Million
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $63.8 Million - $71.8 Million	-1,076,000 Reduced 61.22%	681,500 $43 Million
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $900,744 - $1.02 Million	15,600 Added 0.9%	1,757,500 $109 Million
Q3 2020 Nov 16, 2020	SELL	$57.43 - $63.64 $5.94 Million - $6.59 Million	-103,500 Reduced 5.61%	1,741,900 $105 Million
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $42.2 Million - $49.4 Million	-770,300 Reduced 29.45%	1,845,400 $109 Million
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $32.1 Million - $46.6 Million	-691,400 Reduced 20.91%	2,615,700 $146 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $29.9 Million - $39 Million	607,100 Added 22.49%	3,307,100 $212 Million
Q3 2019 Nov 14, 2019	BUY	$42.77 - $50.71 $7.22 Million - $8.56 Million	168,800 Added 6.67%	2,700,000 $137 Million
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $54.2 Million - $60 Million	1,215,800 Added 92.43%	2,531,200 $115 Million
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $17.4 Million - $20.8 Million	386,600 Added 41.62%	1,315,400 $62.8 Million
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $15.1 Million - $19.5 Million	308,800 Added 49.81%	928,800 $48.3 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $5.11 Million - $5.76 Million	-92,600 Reduced 12.99%	620,000 $38.5 Million
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $16.3 Million - $20.3 Million	322,600 Added 82.72%	712,600 $39.4 Million
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $38.3 Million - $44.1 Million	-639,700 Reduced 62.12%	390,000 $24.7 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $3.88 Million - $4.23 Million	64,700 Added 6.7%	1,029,700 $63.1 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $53.3 Million - $61.5 Million	965,000	965,000 $61.5 Million

Others Institutions Holding BMY

# of Institutions

2,400

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.5 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.08 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.66 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.8 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.01 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $108B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account